4-HO-MiPT

What is 4-HO-MiPT?

4-HO-MiPT, commonly known as Miprocin, is a synthetic psychedelic tryptamine. Its full chemical name is 4-hydroxy-N-methyl-N-isopropyltryptamine. The compound belongs to the same 4-substituted family as psilocin, but one of the methyl groups on psilocin’s terminal nitrogen is replaced by an isopropyl group. This change gives Miprocin a distinct pharmacological profile, even though the two molecules share the same basic indole structure. It should not be confused with 4-HO-MPT (Meprocin), which carries a straight-chain propyl group rather than an isopropyl group.

Chemistry and early descriptions

Alexander and Ann Shulgin included 4-HO-MiPT in TiHKAL in 1997. Their account described it as a particularly intense tryptamine, with a comparatively rapid onset and a longer experience than psilocin in their observations. They also noted that the compound was unstable when exposed to air and light. These are historical observations from a small number of self-experiments, not a controlled clinical characterization, but they remain an important part of the early record.

The chemical relationship to psilocin is straightforward: both compounds carry a hydroxy group at the 4-position of the indole ring. The difference lies at the terminal amine, where Miprocin has one methyl and one isopropyl substituent. Research on substituted tryptamines shows that changes at this position can influence receptor affinity and activity, so the similarity to psilocin should not be taken to mean that the two substances are pharmacologically interchangeable.

Receptor activity

4-HO-MiPT has been examined in several receptor studies. In a 2023 investigation, Kozell and colleagues found that it interacted with 5-HT2A, 5-HT2C and 5-HT1A receptors, as well as the serotonin transporter (SERT). In the functional 5-HT2A assay, Miprocin acted as an agonist with high efficacy. The authors also observed activity at several non-serotonergic targets, although the affinities for many of these were weaker. The results are useful for understanding its pharmacology, but receptor assays cannot reproduce the full experience in a human brain. See Kozell et al. (2023), on the pharmacological activity of substituted tryptamines.

A more recent study, published in 2026, compared 4-HO-MiPT with its 4-methoxy analogue and related compounds. Both 4-HO-MiPT and 4-MeO-MiPT activated 5-HT2A receptors in vitro, but the methoxy compound inhibited SERT more potently. In mice, the two compounds produced similar potency in the head-twitch response, while 4-MeO-MiPT produced a lower maximum response. Pretreatment with fluoxetine reduced the head-twitch response to 4-HO-MiPT, suggesting that serotonin-transporter activity can modify the behavioural effects associated with 5-HT2A activation. This is a preclinical result; it does not establish how Miprocin behaves in people taking antidepressants. The study appeared in ACS Chemical Neuroscience in 2026.

Subjective effects

Descriptions collected by PsychonautWiki and the earlier observations in TiHKAL portray Miprocin as a visually active psychedelic with a pronounced emotional and bodily component. Users often compare it with psilocin, although some describe a more energetic or stimulating character. The reports are anecdotal and vary considerably, so they are best read as a record of possible experiences rather than a predictable profile.

Physical and visual effectsCognitive and emotional effects
  • Visual enhancement: colours may appear more vivid, while fine detail and surface patterns become more noticeable.
  • Visual distortions: drifting surfaces, tracers, afterimages and geometric imagery are described.
  • Bodily sensations: tingling, tactile enhancement and physical euphoria appear in user accounts.
  • Stimulation: some reports describe increased energy and wakefulness, while others emphasize relaxation.
  • Discomfort: nausea, muscle tension and restlessness can occur.
  • Emotional intensity: laughter, euphoria and heightened sensitivity to music or surroundings are reported.
  • Introspection: thoughts may turn toward personal memories, relationships and abstract ideas.
  • Creative associations: users describe unusual connections between ideas and a more fluid train of thought.
  • Time distortion: the passage of time may seem slowed or difficult to estimate.
  • Anxiety: confusion, unease or repetitive thoughts can accompany more difficult experiences.

Descriptions of the experience vary between accounts. The 2026 receptor study adds a possible explanation for some of the complexity: Miprocin interacts with more than one serotonin target, and transporter activity may influence how 5-HT2A-mediated effects are expressed. That mechanism is still being investigated.

What the evidence shows

4-HO-MiPT has a stronger research basis than many newer tryptamines. Its receptor activity has been measured, and the 2026 work adds a more detailed view of its interaction with SERT and 5-HT2A. Even so, controlled human pharmacokinetic studies remain limited. The detailed effects described online and in TiHKAL have not been clinically validated, and the long-term risks have not been adequately characterized.

4-HO-MiPT Products

4-HO-MiPT pellets

4-HO-MiPT pellets

Price range: $315.00 through $1,050.00
Select options
4-HO-MiPT freebase

4-HO-MiPT freebase

Price range: $389.00 through $2,079.00
Select options

Scientific Data

Identity and Structure

Chemical Name4-HO-MiPT
Catalog Entity TypeCompound
FormulaC14H20N2O
Molar Mass232.327 g·mol−1
CAS77872-43-6
CAS Numbers and Substance Forms77872-43-6
Synonyms4-OH-MiPT; 4-Hydroxy-N-methyl-N-isopropyltryptamine; Miprocin
IUPAC Name3-{2-[methyl(propan-2-yl)amino]ethyl}-1H-indol-4-ol
InChIInChI=1S/C14H20N2O/c1-10(2)16(3)8-7-11-9-15-12-5-4-6-13(17)14(11)12/h4-6,9-10,15,17H,7-8H2,1-3H3
InChIKeyRXKGHZCQFXXWFQ-UHFFFAOYSA-N
SMILESCN(C(C)C)CCC2=CNC1=CC=CC(O)=C12

Chemical Identifiers

PubChem CID10082683
ChemSpider ID8258221
UNII4GAJ9OJ8YZ
ChEMBL IDChEMBL171419
CompTox DTXSIDDTXSID30228492

Physical Properties

Melting Point123 to 125 °C (253 to 257 °F)

Clinical Data

Drug ClassNon-selective serotonin receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen
Routes of AdministrationOral
ATC CodeNone

Pharmacokinetics

Onset of Action10–20 minutes
Duration of Action4–6 hours

Legal Status

Legal Status (Wikipedia Source Text)BR: Class F2 (Prohibited psychotropics)
DE: NpSG (Industrial and scientific use only)
UK: Class A
US: Unscheduled

Sources and Attribution

Wikipedia Source URLhttps://en.wikipedia.org/?curid=3051576